Melanoma (Homo sapiens)
From WikiPathways
Description
Melanoma, or malignant melanoma, is a highly aggressive cancer that develops in melanocytes. Many genes have been found to be mutated or amplified in melanoma, with the most commonly mutated genes being BRAF, CDKN2A, NRAS and TP53. MAPK and PI3K/Akt signaling are central to melanoma.
This pathway is a summary of information from figures 1 and 2 from Kunz and Vera and supplemented with information from KEGG.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L; ''A landscape of driver mutations in melanoma.''; Cell, 2012 PubMed Europe PMC Scholia
- ''Genomic Classification of Cutaneous Melanoma.''; Cell, 2015 PubMed Europe PMC Scholia
- Postow MA, Carvajal RD; ''Therapeutic implications of KIT in melanoma.''; Cancer J, 2012 PubMed Europe PMC Scholia
- Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, Cronin JC, Cruz P, Rosenberg SA, Samuels Y; ''Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.''; Nat Genet, 2009 PubMed Europe PMC Scholia
- Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R; ''Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.''; Nat Genet, 2012 PubMed Europe PMC Scholia
- Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E, Ghosh P, Zhang H, Zeid R, Ren X, Cibulskis K, Sivachenko AY, Wagle N, Sucker A, Sougnez C, Onofrio R, Ambrogio L, Auclair D, Fennell T, Carter SL, Drier Y, Stojanov P, Singer MA, Voet D, Jing R, Saksena G, Barretina J, Ramos AH, Pugh TJ, Stransky N, Parkin M, Winckler W, Mahan S, Ardlie K, Baldwin J, Wargo J, Schadendorf D, Meyerson M, Gabriel SB, Golub TR, Wagner SN, Lander ES, Getz G, Chin L, Garraway LA; ''Melanoma genome sequencing reveals frequent PREX2 mutations.''; Nature, 2012 PubMed Europe PMC Scholia
- Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A, Davies MA, Gershenwald JE, Stemke-Hale K, Rosenberg SA, Margulies EH, Samuels Y; ''Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.''; Nat Genet, 2011 PubMed Europe PMC Scholia
- ''''; https://www.kegg.jp/dbget-bin/www_bget?pathway+hsa05218,
- Kunz M, Vera J; ''Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers.''; Cancers (Basel), 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
AKT1 | GeneProduct | ENSG00000142208 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:11651 |
AKT2 | GeneProduct | ENSG00000105221 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:11652 |
AKT3 | GeneProduct | ENSG00000117020 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:23797 |
ARAF | GeneProduct | ENSG00000078061 (Ensembl) | |
BAD | GeneProduct | ENSG00000002330 (Ensembl) |
|
BAK1 | GeneProduct | ENSG00000030110 (Ensembl) | |
BAX | GeneProduct | ENSG00000087088 (Ensembl) | |
BRAF | GeneProduct | 673 (Entrez Gene) | |
Binimetinib | Metabolite | Q19903515 (Wikidata) | |
CALM1 | GeneProduct | ENSG00000198668 (Ensembl) | |
CALM2 | GeneProduct | ENSG00000143933 (Ensembl) | |
CALM3 | GeneProduct | ENSG00000160014 (Ensembl) | |
CALML3 | GeneProduct | ENSG00000178363 (Ensembl) | |
CALML4 | GeneProduct | ENSG00000129007 (Ensembl) | |
CALML5 | GeneProduct | ENSG00000178372 (Ensembl) | |
CALML6 | GeneProduct | ENSG00000169885 (Ensembl) | |
CCND1 | GeneProduct | ENSG00000110092 (Ensembl) | CCND3; cyclin D3 |
CDH1 | GeneProduct | ENSG00000039068 (Ensembl) | |
CDK4 | GeneProduct | ENSG00000135446 (Ensembl) | CDK4; cyclin-dependent kinase 4 [EC:2.7.1.-] |
CDK6 | GeneProduct | ENSG00000105810 (Ensembl) | CDK6; cyclin-dependent kinase 6 [EC:2.7.1.-] |
CDKN1A | GeneProduct | ENSG00000124762 (Ensembl) | |
CREB1 | GeneProduct | ENSG00000118260 (Ensembl) | |
Cobimetinib | Metabolite | Q15708292 (Wikidata) | |
DDB2 | GeneProduct | ENSG00000134574 (Ensembl) | |
Dabrafenib | Metabolite | CHEBI:75045 (ChEBI) | |
E2F1 | GeneProduct | ENSG00000101412 (Ensembl) | E2F1; E2F transcription factor 1 |
E2F2 | GeneProduct | ENSG00000007968 (Ensembl) | E2F2; E2F transcription factor 2 |
E2F3 | GeneProduct | ENSG00000112242 (Ensembl) | E2F3; E2F transcription factor 3 |
ELK1 | GeneProduct | 2002 (Entrez Gene) | |
ERBB4 | GeneProduct | ENSG00000178568 (Ensembl) | |
ETS1 | GeneProduct | ENSG00000134954 (Ensembl) | |
FOS | GeneProduct | 2353 (Entrez Gene) | |
GADD45A | GeneProduct | ENSG00000116717 (Ensembl) | |
GADD45B | GeneProduct | ENSG00000099860 (Ensembl) | |
GADD45G | GeneProduct | ENSG00000130222 (Ensembl) | |
GRB2 | GeneProduct | 2885 (Entrez Gene) | |
GRIN2A | GeneProduct | ENSG00000183454 (Ensembl) | |
GRM3 | GeneProduct | ENSG00000198822 (Ensembl) | |
HRAS | GeneProduct | ENSG00000174775 (Ensembl) | |
KDR | GeneProduct | ENSG00000128052 (Ensembl) | |
KIT | GeneProduct | ENSG00000157404 (Ensembl) | |
KRAS | GeneProduct | 3845 (Entrez Gene) | |
MAP2K1 | GeneProduct | 5604 (Entrez Gene) | |
MAP2K2 | GeneProduct | 5605 (Entrez Gene) | |
MAPK1 | GeneProduct | 5594 (Entrez Gene) | |
MAPK3 | GeneProduct | 5595 (Entrez Gene) | |
MDM2 | GeneProduct | ENSG00000135679 (Ensembl) | |
MITF | GeneProduct | ENSG00000187098 (Ensembl) | |
MP1 | GeneProduct | 8649 (Entrez Gene) | |
NF1 | GeneProduct | ENSG00000196712 (Ensembl) | |
NRAS | GeneProduct | 4893 (Entrez Gene) | |
PAK1 | GeneProduct | ENSG00000149269 (Ensembl) | |
PIK3CA | GeneProduct | ENSG00000121879 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18706 |
PIK3CB | GeneProduct | ENSG00000051382 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:74769 |
PIK3CD | GeneProduct | ENSG00000171608 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18707 |
PIK3R1 | GeneProduct | ENSG00000145675 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18708 |
PIK3R2 | GeneProduct | ENSG00000105647 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18709 |
PIK3R3 | GeneProduct | ENSG00000117461 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:75669 |
PIP3 | Metabolite | HMDB0004249 (HMDB) | |
POLK | GeneProduct | ENSG00000122008 (Ensembl) | |
PREX2 | GeneProduct | ENSG00000046889 (Ensembl) | |
PTEN | GeneProduct | ENSG00000171862 (Ensembl) | Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:19211 |
RAC1 | GeneProduct | ENSG00000136238 (Ensembl) | |
RAF1 | GeneProduct | 5894 (Entrez Gene) | |
RB1 | GeneProduct | ENSG00000139687 (Ensembl) | |
Regorafenib | Metabolite | CHEBI:68647 (ChEBI) | |
Regulation of Actin Cytoskeleton | Pathway | WP51 (WikiPathways) | |
SHC2 | GeneProduct | ENSG00000129946 (Ensembl) | |
SOS1 | GeneProduct | ENSG00000115904 (Ensembl) | |
SOS2 | GeneProduct | 6655 (Entrez Gene) | |
STK19 | GeneProduct | ENSG00000204344 (Ensembl) | |
Sorafenib | Metabolite | HMDB0014542 (HMDB) | |
TP53 | GeneProduct | ENSG00000141510 (Ensembl) | |
VCL | GeneProduct | ENSG00000035403 (Ensembl) | |
Vemurafenib | Metabolite | CHEBI:63637 (ChEBI) | |
p14 ARF (CDKN2A) | GeneProduct | ENSG00000147889 (Ensembl) | |
p16 INK4a (CDKN2A) | GeneProduct | ENSG00000147889 (Ensembl) | |
p38 MAPK Signaling | Pathway | WP400 (WikiPathways) |
Annotated Interactions
No annotated interactions